{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:03:38Z","timestamp":1790787818653,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004962","name":"Conseil R\u00e9gional d'Auvergne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12035-021-02361-6","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T17:02:56Z","timestamp":1616778176000},"page":"3575-3587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity"],"prefix":"10.1007","volume":"58","author":[{"given":"Vanessa","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Lamoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa","family":"Cum\u00e9nal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Lolignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Aissouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pizzoccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Prival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Balayssac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Eschalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bourinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7542-9520","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Busserolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"issue":"23","key":"2361_CR1","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andre","year":"2004","unstructured":"Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343\u20132351","journal-title":"N Engl J Med"},{"issue":"3","key":"2361_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pain.2009.03.024","volume":"144","author":"N Attal","year":"2009","unstructured":"Attal N, Bouhassira D, Gautron M, Vaillant JN, Mitry E, Lepere C et al (2009) Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain. 144(3):245\u2013252","journal-title":"Pain."},{"issue":"1","key":"2361_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1345\/aph.1E319","volume":"39","author":"RJ Cersosimo","year":"2005","unstructured":"Cersosimo RJ (2005) Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 39(1):128\u2013135","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2361_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mus.20340","volume":"32","author":"AV Krishnan","year":"2005","unstructured":"Krishnan AV, Goldstein D, Friedlander M, Kiernan MC (2005) Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve 32(1):51\u201360","journal-title":"Muscle Nerve"},{"issue":"2","key":"2361_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.critrevonc.2006.01.001","volume":"59","author":"LM Pasetto","year":"2006","unstructured":"Pasetto LM, D\u2019Andrea MR, Rossi E, Monfardini S (2006) Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol Hematol 59(2):159\u2013168","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"2361_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ctrv.2008.01.003","volume":"34","author":"AA Argyriou","year":"2008","unstructured":"Argyriou AA, Polychronopoulos P, Iconomou G, Chroni E, Kalofonos HP (2008) A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat Rev 34(4):368\u2013377","journal-title":"Cancer Treat Rev"},{"issue":"16","key":"2361_CR7","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","volume":"18","author":"A de Gramont","year":"2000","unstructured":"de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938\u20132947","journal-title":"J Clin Oncol"},{"issue":"16","key":"2361_CR8","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1200\/JCO.2006.08.6652","volume":"25","author":"SR Land","year":"2007","unstructured":"Land SR, Kopec JA, Cecchini RS, Ganz PA, Wieand HS, Colangelo LH, Murphy K, Kuebler JP et al (2007) Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol 25(16):2205\u20132211","journal-title":"J Clin Oncol"},{"issue":"5","key":"2361_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2010-0248","volume":"16","author":"SB Park","year":"2011","unstructured":"Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC (2011) Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. Oncologist. 16(5):708\u2013716","journal-title":"Oncologist."},{"issue":"1","key":"2361_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000094376","volume":"56","author":"A Pietrangeli","year":"2006","unstructured":"Pietrangeli A, Leandri M, Terzoli E, Jandolo B, Garufi C (2006) Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up. Eur Neurol 56(1):13\u201316","journal-title":"Eur Neurol"},{"issue":"18","key":"2361_CR11","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/S0959-8049(01)00300-8","volume":"37","author":"G Cavaletti","year":"2001","unstructured":"Cavaletti G, Tredici G, Petruccioli MG, Donde E, Tredici P, Marmiroli P et al (2001) Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer 37(18):2457\u20132463","journal-title":"Eur J Cancer"},{"issue":"4","key":"2361_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00280-004-0953-4","volume":"56","author":"SM Jamieson","year":"2005","unstructured":"Jamieson SM, Liu J, Connor B, McKeage MJ (2005) Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss. Cancer Chemother Pharmacol 56(4):391\u2013399","journal-title":"Cancer Chemother Pharmacol"},{"key":"2361_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neuroscience.2011.12.023","volume":"203","author":"WH Xiao","year":"2012","unstructured":"Xiao WH, Zheng H, Bennett GJ (2012) Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience. 203:194\u2013206","journal-title":"Neuroscience."},{"issue":"5","key":"2361_CR14","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1152\/jn.2001.85.5.2293","volume":"85","author":"F Grolleau","year":"2001","unstructured":"Grolleau F, Gamelin L, Boisdron-Celle M, Lapied B, Pelhate M, Gamelin E (2001) A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 85(5):2293\u20132297","journal-title":"J Neurophysiol"},{"key":"2361_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1744-8069-8-7","volume":"8","author":"T Kawashiri","year":"2012","unstructured":"Kawashiri T, Egashira N, Kurobe K, Tsutsumi K, Yamashita Y, Ushio S et al (2012) L type Ca(2)+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats. Mol Pain 8:7","journal-title":"Mol Pain"},{"issue":"4","key":"2361_CR16","doi-asserted-by":"publisher","first-page":"e18469","DOI":"10.1371\/journal.pone.0018469","volume":"6","author":"SB Park","year":"2011","unstructured":"Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC (2011) Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity. PLoS One 6(4):e18469","journal-title":"PLoS One"},{"issue":"5","key":"2361_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/emmm.201100134","volume":"3","author":"J Descoeur","year":"2011","unstructured":"Descoeur J, Pereira V, Pizzoccaro A, Francois A, Ling B, Maffre V, Couette B, Busserolles J et al (2011) Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med 3(5):266\u2013278","journal-title":"EMBO Mol Med"},{"issue":"2","key":"2361_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neulet.2009.04.029","volume":"458","author":"P Gauchan","year":"2009","unstructured":"Gauchan P, Andoh T, Kato A, Kuraishi Y (2009) Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice. Neurosci Lett 458(2):93\u201395","journal-title":"Neurosci Lett"},{"issue":"7","key":"2361_CR19","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.pain.2011.02.051","volume":"152","author":"R Nassini","year":"2011","unstructured":"Nassini R, Gees M, Harrison S, De Siena G, Materazzi S, Moretto N et al (2011) Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain. 152(7):1621\u20131631","journal-title":"Pain."},{"issue":"12","key":"2361_CR20","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/j.pain.2014.09.013","volume":"155","author":"V Pereira","year":"2014","unstructured":"Pereira V, Busserolles J, Christin M, Devilliers M, Poupon L, Legha W, Alloui A, Aissouni Y et al (2014) Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception. Pain. 155(12):2534\u20132544","journal-title":"Pain."},{"issue":"11","key":"2361_CR21","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/sj.emboj.7601116","volume":"25","author":"A Alloui","year":"2006","unstructured":"Alloui A, Zimmermann K, Mamet J, Duprat F, Noel J, Chemin J et al (2006) TREK-1, a K+ channel involved in polymodal pain perception. EMBO J 25(11):2368\u20132376","journal-title":"EMBO J"},{"issue":"9","key":"2361_CR22","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/emboj.2009.57","volume":"28","author":"J Noel","year":"2009","unstructured":"Noel J, Zimmermann K, Busserolles J, Deval E, Alloui A, Diochot S et al (2009) The mechano-activated K+ channels TRAAK and TREK-1 control both warm and cold perception. EMBO J 28(9):1308\u20131318","journal-title":"EMBO J"},{"issue":"3","key":"2361_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1021\/acs.jmedchem.6b01285","volume":"60","author":"D Vivier","year":"2017","unstructured":"Vivier D, Soussia IB, Rodrigues N, Lolignier S, Devilliers M, Chatelain FC, Prival L, Chapuy E et al (2017) Development of the first two-pore domain potassium channel TWIK-related K+ channel 1-selective agonist possessing in vivo antinociceptive activity. J Med Chem 60(3):1076\u20131088","journal-title":"J Med Chem"},{"key":"2361_CR24","doi-asserted-by":"crossref","unstructured":"Busserolles J, Tsantoulas C, Eschalier A, Lopez Garcia JA (2016) Potassium channels in neuropathic pain: advances, challenges, and emerging ideas. Pain. 157(Suppl 1):S7\u2013S14","DOI":"10.1097\/j.pain.0000000000000368"},{"issue":"13","key":"2361_CR25","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1523\/JNEUROSCI.5541-09.2010","volume":"30","author":"H Uchida","year":"2010","unstructured":"Uchida H, Ma L, Ueda H (2010) Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci 30(13):4806\u20134814","journal-title":"J Neurosci"},{"issue":"51","key":"2361_CR26","doi-asserted-by":"publisher","first-page":"85564","DOI":"10.18632\/oncotarget.9447","volume":"7","author":"D Wang","year":"2016","unstructured":"Wang D, Yu J (2016) Negative regulation of REST on NR2B in spinal cord contributes to the development of bone cancer pain in mice. Oncotarget. 7(51):85564\u201385572","journal-title":"Oncotarget."},{"key":"2361_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2015.12.003","volume":"625","author":"DE Willis","year":"2016","unstructured":"Willis DE, Wang M, Brown E, Fones L, Cave JW (2016) Selective repression of gene expression in neuropathic pain by the neuron-restrictive silencing factor\/repressor element-1 silencing transcription (NRSF\/REST). Neurosci Lett 625:20\u201325","journal-title":"Neurosci Lett"},{"issue":"10","key":"2361_CR28","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1097\/j.pain.0000000000001633","volume":"160","author":"F Zhang","year":"2019","unstructured":"Zhang F, Gigout S, Liu Y, Wang Y, Hao H, Buckley NJ, Zhang H, Wood IC et al (2019) Repressor element 1-silencing transcription factor drives the development of chronic pain states. Pain. 160(10):2398\u20132408","journal-title":"Pain."},{"issue":"5","key":"2361_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/j.pain.0000000000000848","volume":"158","author":"C Zhu","year":"2017","unstructured":"Zhu C, Tang J, Ding T, Chen L, Wang W, Mei XP, He XT, Wang W et al (2017) Neuron-restrictive silencer factor-mediated downregulation of mu-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain. Pain. 158(5):879\u2013890","journal-title":"Pain."},{"issue":"22","key":"2361_CR30","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.4161\/cc.9.22.13973","volume":"9","author":"IA Qureshi","year":"2010","unstructured":"Qureshi IA, Gokhan S, Mehler MF (2010) REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions. Cell Cycle 9(22):4477\u20134486","journal-title":"Cell Cycle"},{"issue":"17","key":"2361_CR31","doi-asserted-by":"publisher","first-page":"9873","DOI":"10.1073\/pnas.96.17.9873","volume":"96","author":"ME Andres","year":"1999","unstructured":"Andres ME, Burger C, Peral-Rubio MJ, Battaglioli E, Anderson ME, Grimes J, Dallman J, Ballas N et al (1999) CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc Natl Acad Sci U S A 96(17):9873\u20139878","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2361_CR32","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1073\/pnas.98.4.1454","volume":"98","author":"A You","year":"2001","unstructured":"You A, Tong JK, Grozinger CM, Schreiber SL (2001) CoREST is an integral component of the CoREST- human histone deacetylase complex. Proc Natl Acad Sci U S A 98(4):1454\u20131458","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2361_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2009.12.021","volume":"166","author":"H Uchida","year":"2010","unstructured":"Uchida H, Sasaki K, Ma L, Ueda H (2010) Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury. Neuroscience. 166(1):1\u20134","journal-title":"Neuroscience."},{"issue":"4","key":"2361_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jphs.2015.07.040","volume":"128","author":"H Uchida","year":"2015","unstructured":"Uchida H, Matsushita Y, Araki K, Mukae T, Ueda H (2015) Histone deacetylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury. J Pharmacol Sci 128(4):208\u2013211","journal-title":"J Pharmacol Sci"},{"issue":"28","key":"2361_CR35","doi-asserted-by":"publisher","first-page":"10458","DOI":"10.1073\/pnas.0401827101","volume":"101","author":"AW Bruce","year":"2004","unstructured":"Bruce AW, Donaldson IJ, Wood IC, Yerbury SA, Sadowski MI, Chapman M, Gottgens B, Buckley NJ (2004) Genome-wide analysis of repressor element 1 silencing transcription factor\/neuron-restrictive silencing factor (REST\/NRSF) target genes. Proc Natl Acad Sci U S A 101(28):10458\u201310463","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2361_CR36","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/sj.emboj.7600234","volume":"23","author":"C Heurteaux","year":"2004","unstructured":"Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, Lang-Lazdunski L, Widmann C et al (2004) TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J 23(13):2684\u20132695","journal-title":"EMBO J"},{"issue":"8","key":"2361_CR37","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1523\/JNEUROSCI.5764-08.2009","volume":"29","author":"A Guyon","year":"2009","unstructured":"Guyon A, Tardy MP, Rovere C, Nahon JL, Barhanin J, Lesage F (2009) Glucose inhibition persists in hypothalamic neurons lacking tandem-pore K+ channels. J Neurosci 29(8):2528\u20132533","journal-title":"J Neurosci"},{"key":"2361_CR38","first-page":"502","volume":"13","author":"PA Janssen","year":"1963","unstructured":"Janssen PA, Niemegeers CJ, Dony JG (1963) The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawl reflex in rats. Arzneimittelforschung. 13:502\u2013507","journal-title":"Arzneimittelforschung."},{"issue":"7","key":"2361_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jpain.2009.01.325","volume":"10","author":"I Yalcin","year":"2009","unstructured":"Yalcin I, Charlet A, Freund-Mercier MJ, Barrot M, Poisbeau P (2009) Differentiating thermal allodynia and hyperalgesia using dynamic hot and cold plate in rodents. J Pain 10(7):767\u2013773","journal-title":"J Pain"},{"issue":"2-3","key":"2361_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","volume":"67","author":"JL Hylden","year":"1980","unstructured":"Hylden JL, Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67(2-3):313\u2013316","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2361_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/nar\/gkj460","volume":"34","author":"A Saramaki","year":"2006","unstructured":"Saramaki A, Banwell CM, Campbell MJ, Carlberg C (2006) Regulation of the human p21(waf1\/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34(2):543\u2013554","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2361_CR42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/nar\/gkg108","volume":"31","author":"V Matys","year":"2003","unstructured":"Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R et al (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31(1):374\u2013378","journal-title":"Nucleic Acids Res"},{"issue":"24","key":"2361_CR43","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1038\/sj.emboj.7601437","volume":"25","author":"G Sandoz","year":"2006","unstructured":"Sandoz G, Thummler S, Duprat F, Feliciangeli S, Vinh J, Escoubas P et al (2006) AKAP150, a switch to convert mechano-, pH- and arachidonic acid-sensitive TREK K(+) channels into open leak channels. EMBO J 25(24):5864\u20135872","journal-title":"EMBO J"},{"issue":"34","key":"2361_CR44","doi-asserted-by":"publisher","first-page":"8545","DOI":"10.1523\/JNEUROSCI.1962-08.2008","volume":"28","author":"G Sandoz","year":"2008","unstructured":"Sandoz G, Tardy MP, Thummler S, Feliciangeli S, Lazdunski M, Lesage F (2008) Mtap2 is a constituent of the protein network that regulates twik-related K+ channel expression and trafficking. J Neurosci 28(34):8545\u20138552","journal-title":"J Neurosci"},{"issue":"19","key":"2361_CR45","doi-asserted-by":"publisher","first-page":"7332","DOI":"10.1523\/JNEUROSCI.2174-14.2015","volume":"35","author":"L Formisano","year":"2015","unstructured":"Formisano L, Guida N, Valsecchi V, Cantile M, Cuomo O, Vinciguerra A, Laudati G, Pignataro G et al (2015) Sp3\/REST\/HDAC1\/HDAC2 complex represses and Sp1\/HIF-1\/p300 complex activates ncx1 gene transcription, in brain ischemia and in ischemic brain preconditioning, by epigenetic mechanism. J Neurosci 35(19):7332\u20137348","journal-title":"J Neurosci"},{"key":"2361_CR46","doi-asserted-by":"publisher","first-page":"45047","DOI":"10.1038\/srep45047","volume":"7","author":"NG Leus","year":"2017","unstructured":"Leus NG, van den Bosch T, van der Wouden PE, Krist K, Ourailidou ME, Eleftheriadis N et al (2017) HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice. Sci Rep 7:45047","journal-title":"Sci Rep"},{"issue":"5","key":"2361_CR47","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/ijc.22751","volume":"121","author":"T Beckers","year":"2007","unstructured":"Beckers T, Burkhardt C, Wieland H, Gimmnich P, Ciossek T, Maier T, Sanders K (2007) Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int J Cancer 121(5):1138\u20131148","journal-title":"Int J Cancer"},{"key":"2361_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1744-8069-6-51","volume":"6","author":"G Bai","year":"2010","unstructured":"Bai G, Wei D, Zou S, Ren K, Dubner R (2010) Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Mol Pain 6:51","journal-title":"Mol Pain"},{"issue":"3","key":"2361_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/WNR.0b013e32835d8431","volume":"24","author":"J Zhou","year":"2013","unstructured":"Zhou J, Yang CX, Zhong JY, Wang HB (2013) Intrathecal TRESK gene recombinant adenovirus attenuates spared nerve injury-induced neuropathic pain in rats. Neuroreport. 24(3):131\u2013136","journal-title":"Neuroreport."},{"issue":"5","key":"2361_CR50","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1471-4159.2010.06863.x","volume":"114","author":"XH Cao","year":"2010","unstructured":"Cao XH, Byun HS, Chen SR, Cai YQ, Pan HL (2010) Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor. J Neurochem 114(5):1460\u20131475","journal-title":"J Neurochem"},{"issue":"1","key":"2361_CR51","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1471-4159.2009.06138.x","volume":"110","author":"SR Chen","year":"2009","unstructured":"Chen SR, Cai YQ, Pan HL (2009) Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain. J Neurochem 110(1):352\u2013362","journal-title":"J Neurochem"},{"issue":"23","key":"2361_CR52","doi-asserted-by":"publisher","first-page":"13373","DOI":"10.1073\/pnas.231376298","volume":"98","author":"MN Rasband","year":"2001","unstructured":"Rasband MN, Park EW, Vanderah TW, Lai J, Porreca F, Trimmer JS (2001) Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci U S A 98(23):13373\u201313378","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2361_CR53","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.pain.2010.12.028","volume":"152","author":"K Rose","year":"2011","unstructured":"Rose K, Ooi L, Dalle C, Robertson B, Wood IC, Gamper N (2011) Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain. 152(4):742\u2013754","journal-title":"Pain."},{"issue":"19","key":"2361_CR54","doi-asserted-by":"publisher","first-page":"7164","DOI":"10.3390\/ijms21197164","volume":"21","author":"M Dionisi","year":"2020","unstructured":"Dionisi M, Ruffinatti FA, Riva B, Lim D, Canta A, Meregalli C et al (2020) Early stimulation of TREK channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification. Int J Mol Sci 21(19):7164","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2361_CR55","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1113\/JP279203","volume":"598","author":"A Castellanos","year":"2020","unstructured":"Castellanos A, Pujol-Coma A, Andres-Bilbe A, Negm A, Callejo G, Soto D, No\u00ebl J, Comes N et al (2020) TRESK background K(+) channel deletion selectively uncovers enhanced mechanical and cold sensitivity. J Physiol 598(5):1017\u20131038","journal-title":"J Physiol"},{"key":"2361_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2011.08.040","volume":"1418","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liu C, Guo QL, Yan JQ, Zhu XY, Huang CS, Zou WY (2011) Intrathecal 5-azacytidine inhibits global DNA methylation and methyl- CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic constriction injury. Brain Res 1418:64\u201369","journal-title":"Brain Res"},{"issue":"11","key":"2361_CR57","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/nm.2442","volume":"17","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Cai YQ, Zou F, Bie B, Pan ZZ (2011) Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 17(11):1448\u20131455","journal-title":"Nat Med"},{"key":"2361_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1744-8069-8-14","volume":"8","author":"KK Tochiki","year":"2012","unstructured":"Tochiki KK, Cunningham J, Hunt SP, Geranton SM (2012) The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states. Mol Pain 8:14","journal-title":"Mol Pain"},{"issue":"5202","key":"2361_CR59","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1126\/science.7871435","volume":"267","author":"CJ Schoenherr","year":"1995","unstructured":"Schoenherr CJ, Anderson DJ (1995) The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science. 267(5202):1360\u20131363","journal-title":"Science."},{"issue":"25","key":"2361_CR60","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1523\/JNEUROSCI.0091-07.2007","volume":"27","author":"SJ Otto","year":"2007","unstructured":"Otto SJ, McCorkle SR, Hover J, Conaco C, Han JJ, Impey S et al (2007) A new binding motif for the transcriptional repressor REST uncovers large gene networks devoted to neuronal functions. J Neurosci 27(25):6729\u20136739","journal-title":"J Neurosci"},{"issue":"49","key":"2361_CR61","doi-asserted-by":"publisher","first-page":"19078","DOI":"10.1074\/jbc.RA118.005846","volume":"293","author":"J Zhang","year":"2018","unstructured":"Zhang J, Chen SR, Chen H, Pan HL (2018) RE1-silencing transcription factor controls the acute-to-chronic neuropathic pain transition and Chrm2 receptor gene expression in primary sensory neurons. J Biol Chem 293(49):19078\u201319091","journal-title":"J Biol Chem"},{"issue":"1","key":"2361_CR62","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12031-014-0298-3","volume":"55","author":"B Alani","year":"2015","unstructured":"Alani B, Salehi R, Sadeghi P, Khodagholi F, Digaleh H, Jabbarzadeh-Tabrizi S, Zare M, Korbekandi H (2015) Silencing of Hsp70 intensifies 6-OHDA-induced apoptosis and Hsp90 upregulation in PC12 cells. J Mol Neurosci 55(1):174\u2013183","journal-title":"J Mol Neurosci"},{"issue":"3","key":"2361_CR63","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12031-013-0163-9","volume":"52","author":"B Alani","year":"2014","unstructured":"Alani B, Salehi R, Sadeghi P, Zare M, Khodagholi F, Arefian E, Hakemi MG, Digaleh H (2014) Silencing of Hsp90 chaperone expression protects against 6-hydroxydopamine toxicity in PC12 cells. J Mol Neurosci 52(3):392\u2013402","journal-title":"J Mol Neurosci"},{"issue":"40","key":"2361_CR64","doi-asserted-by":"publisher","first-page":"13235","DOI":"10.1523\/JNEUROSCI.1981-10.2010","volume":"30","author":"M Mucha","year":"2010","unstructured":"Mucha M, Ooi L, Linley JE, Mordaka P, Dalle C, Robertson B, Gamper N, Wood IC (2010) Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability. J Neurosci 30(40):13235\u201313245","journal-title":"J Neurosci"},{"key":"2361_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/neuro.02.003.2009","volume":"2","author":"TR Phuket","year":"2009","unstructured":"Phuket TR, Covarrubias M (2009) Kv4 channels underlie the subthreshold-operating A-type K-current in nociceptive dorsal root ganglion neurons. Front Mol Neurosci 2:3","journal-title":"Front Mol Neurosci"},{"issue":"1-2","key":"2361_CR66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pharmthera.2005.06.003","volume":"109","author":"H Ueda","year":"2006","unstructured":"Ueda H (2006) Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol Ther 109(1-2):57\u201377","journal-title":"Pharmacol Ther"},{"issue":"7","key":"2361_CR67","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrg2100","volume":"8","author":"L Ooi","year":"2007","unstructured":"Ooi L, Wood IC (2007) Chromatin crosstalk in development and disease: lessons from REST. Nat Rev Genet 8(7):544\u2013554","journal-title":"Nat Rev Genet"},{"issue":"5","key":"2361_CR68","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/bph.12366","volume":"170","author":"Y Matsushita","year":"2013","unstructured":"Matsushita Y, Araki K, Omotuyi O, Mukae T, Ueda H (2013) HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model. Br J Pharmacol 170(5):991\u2013998","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2361_CR69","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.114.219345","volume":"352","author":"L Formisano","year":"2015","unstructured":"Formisano L, Guida N, Laudati G, Mascolo L, Di Renzo G, Canzoniero LM (2015) MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3\/REST complex on the synapsin-1 promoter. J Pharmacol Exp Ther 352(2):236\u2013243","journal-title":"J Pharmacol Exp Ther"},{"issue":"42","key":"2361_CR70","doi-asserted-by":"publisher","first-page":"35444","DOI":"10.1074\/jbc.M112.394544","volume":"287","author":"FH Bardai","year":"2012","unstructured":"Bardai FH, Price V, Zaayman M, Wang L, D\u2019Mello SR (2012) Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death. J Biol Chem 287(42):35444\u201335453","journal-title":"J Biol Chem"},{"issue":"5","key":"2361_CR71","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1523\/JNEUROSCI.5704-10.2011","volume":"31","author":"FH Bardai","year":"2011","unstructured":"Bardai FH, D\u2019Mello SR (2011) Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta. J Neurosci 31(5):1746\u20131751","journal-title":"J Neurosci"},{"issue":"9","key":"2361_CR72","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.pain.2013.05.021","volume":"154","author":"F Denk","year":"2013","unstructured":"Denk F, Huang W, Sidders B, Bithell A, Crow M, Grist J, Sharma S, Ziemek D et al (2013) HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain. Pain. 154(9):1668\u20131679","journal-title":"Pain."},{"key":"2361_CR73","doi-asserted-by":"publisher","first-page":"174480691879676","DOI":"10.1177\/1744806918796763","volume":"14","author":"RJ Danaher","year":"2018","unstructured":"Danaher RJ, Zhang L, Donley CJ, Laungani NA, Hui SE, Miller CS et al (2018) Histone deacetylase inhibitors prevent persistent hypersensitivity in an orofacial neuropathic pain model. Mol Pain 14:1744806918796763","journal-title":"Mol Pain"},{"issue":"7","key":"2361_CR74","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.bbadis.2014.02.006","volume":"1842","author":"AG Vaiopoulos","year":"2014","unstructured":"Vaiopoulos AG, Athanasoula K, Papavassiliou AG (2014) Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges. Biochim Biophys Acta 1842(7):971\u2013980","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2361_CR75","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1248\/bpb.b13-00574","volume":"37","author":"M Ikehata","year":"2014","unstructured":"Ikehata M, Ogawa M, Yamada Y, Tanaka S, Ueda K, Iwakawa S (2014) Different effects of epigenetic modifiers on the cytotoxicity induced by 5-fluorouracil, irinotecan or oxaliplatin in colon cancer cells. Biol Pharm Bull 37(1):67\u201373","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"2361_CR76","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10549-013-2784-7","volume":"143","author":"P Shah","year":"2014","unstructured":"Shah P, Gau Y, Sabnis G (2014) Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin. Breast Cancer Res Treat 143(1):99\u2013111","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2361_CR77","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3892\/or.2015.3879","volume":"33","author":"M Ji","year":"2015","unstructured":"Ji M, Lee EJ, Kim KB, Kim Y, Sung R, Lee SJ et al (2015) HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. Oncol Rep 33(5):2299\u20132308","journal-title":"Oncol Rep"},{"issue":"7","key":"2361_CR78","doi-asserted-by":"publisher","first-page":"e0200015","DOI":"10.1371\/journal.pone.0200015","volume":"13","author":"T Tomono","year":"2018","unstructured":"Tomono T, Machida T, Kamioka H, Shibasaki Y, Yano K, Ogihara T (2018) Entinostat reverses P-glycoprotein activation in snail-overexpressing adenocarcinoma HCC827 cells. PLoS One 13(7):e0200015","journal-title":"PLoS One"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02361-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T22:43:56Z","timestamp":1724712236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02361-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":78,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2361"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02361-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"9 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the animal procedures were approved by the local Animal Ethics Committee and the experiments were performed according to the guidelines provided by the European Community on the care and use of animals (Directive 2010\/63\/EU).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}